Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy

Abstract
No abstract available
Funding Information
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Department of Health and Human Services (N01-AI-60019)
  • CANVAC (HIV-001)
  • Canadian trials Network (CTN) Study No. 229

This publication has 40 references indexed in Scilit: